PRKN and Parkinson disease: This indicates an asymmetric reduction of radioligand uptake in the putamen of PD associated with GBA and LRRK2 mutations with a relatively symmetrical reduction in ligand uptake in the putamen of PINK1, Parkin and SNCA mutation associated PD.